Efavirenz to Nevirapine Switch and Low-Density Lipoprotein (LDL)-Dyslipidemia

NCT00405171 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections
Hypercholesterolemia
Antiretroviral Therapy

Interventions

DRUG: Nevirapine

Sponsor

University Hospital, Caen

Collaborators

[object Object]